Cocrystal Pharma (COCP) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist

1.7600
+0.0100+0.57%

Close Nov 12 16:00 ET

1.7600
0.00000.00%

Post 20:01 ET

17.91MMarket Cap-1005P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaNov 5 07:05 ET
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation
Yahoo FinanceOct 18 06:45 ET
Cocrystal Pharma Boosts Executive and Director Compensation
TipRanksOct 10 17:28 ET
Cocrystal Pharma Advances CDI-988 Into Phase 1 MAD Cohorts
TipRanksSep 26 08:20 ET
Express News | Cocrystal Pharma Inc: Topline Study Results Are Expected in Late 2024 or Early 2025
ReutersSep 26 08:03 ET
Express News | Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor Cdi-988 Into Phase 1 Multiple-Ascending Dose Cohorts
ReutersSep 26 08:00 ET

Comments

Jaguar8

Jul 18 07:01

NEWS

$Cocrystal Pharma (COCP.US)$
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Cocrystal Pharma (Nasdaq: COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of its Phase 1 study for CDI-988, an oral pan-viral norovirus/coronavirus protease inhibitor.
The study, conducted in Australia, evaluated doses ranging from 100 mg to 60...

Jaguar8

May 1 11:47

$Cocrystal Pharma (COCP.US)$
NEWS
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza